Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status, Trends and
In the past few years, the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market
experienced a huge change under the influence of COVID-19, the global market size of
Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors reached xx million $ in 2021 from xx
in 2016 with a CAGR of xx from 2016-2021 is. As of now, the global COVID-19 Coronavirus
Cases have exceeded 500 million, and the global epidemic has been basically under control,
therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The
World Bank predicts that the global economic output is expected to expand 4 percent in
2021 while 3.8 percent in 2022. According to our research on Sodium/Glucose
Cotransporter 2 (SGLT 2) Inhibitors market and global economic environment, we forecast
that the global market size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors will
reach xx million $ in 2027 with a CAGR of % from 2022-2027.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Market Status, Trends and COVID-19 Impact Report 2022, which provides a
comprehensive analysis of the global Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors market , This Report covers the manufacturer data, including: sales volume,
price, revenue, gross margin, business distribution etc., these data help the consumer know
about the competitors better. This report also covers all the regions and countries of the
world, which shows the regional development status, including market size, volume and
value, as well as price data. Besides, the report also covers segment data, including: type
wise, industry wise, channel wise etc. all the data period is from 2016-2021, this report also
provide forecast data from 2022-2027.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca
Bristol Myers Squibb
Kotobuki Pharmaceutical
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)
Application Segmentation
Hospital
Medical Research Institute
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2022-2027)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
experienced a huge change under the influence of COVID-19, the global market size of
Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors reached xx million $ in 2021 from xx
in 2016 with a CAGR of xx from 2016-2021 is. As of now, the global COVID-19 Coronavirus
Cases have exceeded 500 million, and the global epidemic has been basically under control,
therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The
World Bank predicts that the global economic output is expected to expand 4 percent in
2021 while 3.8 percent in 2022. According to our research on Sodium/Glucose
Cotransporter 2 (SGLT 2) Inhibitors market and global economic environment, we forecast
that the global market size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors will
reach xx million $ in 2027 with a CAGR of % from 2022-2027.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Market Status, Trends and COVID-19 Impact Report 2022, which provides a
comprehensive analysis of the global Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors market , This Report covers the manufacturer data, including: sales volume,
price, revenue, gross margin, business distribution etc., these data help the consumer know
about the competitors better. This report also covers all the regions and countries of the
world, which shows the regional development status, including market size, volume and
value, as well as price data. Besides, the report also covers segment data, including: type
wise, industry wise, channel wise etc. all the data period is from 2016-2021, this report also
provide forecast data from 2022-2027.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca
Bristol Myers Squibb
Kotobuki Pharmaceutical
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)
Application Segmentation
Hospital
Medical Research Institute
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2022-2027)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
SECTION 1 SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET OVERVIEW
1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Scope
1.2 COVID-19 Impact on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
1.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status and Forecast
Overview
1.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status 2016-2021
1.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast 2022-
2027
SECTION 2 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET MANUFACTURER
Share
2.1 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume
2.2 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Revenue
SECTION 3 MANUFACTURER SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BUSINESS
Introduction
3.1 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.1.1 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price,
Revenue and Gross margin 2016-2021
3.1.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution by
Region
3.1.3 Eli Lilly Interview Record
3.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Profile
3.1.5 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
3.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Introduction
3.2.1 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales
Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Business Distribution by Region
3.2.3 Interview Record
3.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Business Overview
3.2.5 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Product Specification
3.3 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Introduction
3.3.1 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales
Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Overview
3.3.5 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product
Specification
SECTION 4 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
(By Region)
4.1 North America Country
4.1.1 United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and
Price Analysis 2016-2021
4.1.2 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.1.3 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.2.2 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.3 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.4 Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.5 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and
Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.2 UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.3 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.4 Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.5 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.5.2 Middle East Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and
Price Analysis 2016-2021
4.6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Region) Analysis 2016-2021
4.7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Region) Analysis
SECTION 5 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
(by Product Type)
5.1 Product Introduction by Type
5.1.1 Invokana (Canagliflozin) Product Introduction
5.1.2 Jardiance (Empagliflozin) Product Introduction
5.1.3 Farxiga/Forxiga (Dapagliflozin) Product Introduction
5.1.4 Suglat (Ipragliflozin) Product Introduction
5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Jardiance
(Empagliflozin)016-2021
5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Jardiance
(Empagliflozin)016-2021
5.4 Different Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type Price
2016-2021
5.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Type) Analysis
SECTION 6 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
(by Application)
6.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by
Application 2016-2021
6.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application
2016-2021
6.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price in Different Application
Field 2016-2021
6.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Application) Analysis
SECTION 7 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Scope
1.2 COVID-19 Impact on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
1.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status and Forecast
Overview
1.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status 2016-2021
1.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast 2022-
2027
SECTION 2 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET MANUFACTURER
Share
2.1 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume
2.2 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Revenue
SECTION 3 MANUFACTURER SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BUSINESS
Introduction
3.1 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.1.1 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price,
Revenue and Gross margin 2016-2021
3.1.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution by
Region
3.1.3 Eli Lilly Interview Record
3.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Profile
3.1.5 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
3.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Introduction
3.2.1 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales
Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Business Distribution by Region
3.2.3 Interview Record
3.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Business Overview
3.2.5 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2)
Inhibitors Product Specification
3.3 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Introduction
3.3.1 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales
Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business
Overview
3.3.5 Manufacturer three Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product
Specification
SECTION 4 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
(By Region)
4.1 North America Country
4.1.1 United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and
Price Analysis 2016-2021
4.1.2 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.1.3 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.2.2 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.3 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.4 Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.3.5 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and
Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.2 UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.3 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.4 Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.4.5 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price
Analysis 2016-2021
4.5.2 Middle East Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and
Price Analysis 2016-2021
4.6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Region) Analysis 2016-2021
4.7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Region) Analysis
SECTION 5 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
(by Product Type)
5.1 Product Introduction by Type
5.1.1 Invokana (Canagliflozin) Product Introduction
5.1.2 Jardiance (Empagliflozin) Product Introduction
5.1.3 Farxiga/Forxiga (Dapagliflozin) Product Introduction
5.1.4 Suglat (Ipragliflozin) Product Introduction
5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Jardiance
(Empagliflozin)016-2021
5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Jardiance
(Empagliflozin)016-2021
5.4 Different Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type Price
2016-2021
5.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Type) Analysis
SECTION 6 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
(by Application)
6.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by
Application 2016-2021
6.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application
2016-2021
6.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price in Different Application
Field 2016-2021
6.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (By
Application) Analysis
SECTION 7 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS MARKET SEGMENTATION
